In the second season of The Fundamentals podcast, co-hosts Kelly Malcom and Jordan Goebig talk to several leading experts from the Medical School about their fields and the fundamental questions they are trying to answer — and discover why U-M is such an amazing place for research. Six new episodes of the popular podcast were released on May 6

Dr. Jody Platt. She is an Associate Professor of Learning Health Sciences at the University of Michigan Medical School. Trained in medical sociology and health policy, her research focuses on issues at the intersection of informatics and ethics. She is interested in understanding what makes data-driven health trusted, and the pathways for earning, achieving, and sustaining trust across stakeholders. Dr. Platt is the Academy Health and ABIM Foundation Senior Scholar in Residence advising on issues of measuring and building trust.

Experts in brain cancer outline current discoveries and offer a path of hope for glioblastoma treatment

A recent U-M study uncovers a pathway utilized during normal wound healing that has the potential to reverse idiopathic pulmonary fibrosis.

At-home test can detect tumor DNA fragments in urine samples, providing a non-invasive alternative to traditional blood-based biomarker tests

An updated rat reference provides more accuracy for research; could help researchers using rat models for the study of DNA, RNA, evolution, or genes linked to disease risks

Six members of the University of Michigan community were inducted into the National Academies of Practice (NAP) as Distinguished Fellows in a ceremony held on March 16, 2024 in Jacksonville, Florida as part of the Annual NAP Meeting and Forum. The group includes faculty and clinicians from the University of Michigan, University of Michigan-Flint and Michigan Medicine.

Using a chip to process blood samples, doctors can monitor the amount of cancer cells in a patient’s blood to determine how well a treatment is working by the fourth week, according to a new study.

Surgery patients who drink at a risky level have higher risks of complications; surgical teams could use artificial intelligence to search their records for signs that they may need to cut back.

Recently approved by the Food and Drug Administration, Pluvicto is a radionuclide-labelled drug administered to patients showing promising results.

Findings from researchers at the University of Michigan Health Rogel Cancer Center, published in Cancer Discovery, show how a specific nucleotide metabolite called GTP controls responses to radiation and chemotherapy in an unexpected way.

Medical students who reported a disability to their school increased by more than 25% during the COVID-19 pandemic, a study shows.

AI can predict certain forms of esophageal and stomach cancer Michigan Medicine study says.

There are 13 U-M graduate medical education programs ranked in the top 10 by Doximity.